Quantcast
Viewing all articles
Browse latest Browse all 1724

Edelinontrine

Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.
Image may be NSFW.
Clik here to view.

Edelinontrine

CRD740, PF04447943, cas 1082744-20-4

Molecular Weight395.46
FormulaC20H25N7O2

6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(oxan-4-yl)-5H-pyrazolo[3,4-d]pyrimidin-4-one

Edelinontrine (PF-04447943) is a potent inhibitor of human recombinant PDE9A (IC50=12 nM) with >78-fold selectivity, respectively, over other PDE family members (IC50>1000 nM).

Image may be NSFW.
Clik here to view.

PF-04447943 is a potent, selective brain penetrant PDE9 inhibitor (Ki of 2.8, 4.5 and 18 nM) for human, rhesus and rat recombinant PDE9 respectively and high selectivity for PDE9 versus PDEs1-8 and 10-11. PF-04447943 was being developed by Pfizer for the treatment of cognitive disorders. PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task. PF-04447943 enhances synaptic plasticity and cognitive function in rodents. PF-04447943 has completed Phase II clinical trials in subjects with mild to moderate AD in 2013 but this research was discontinued. Pfizer completes a phase I trial in Sickle cell anaemia.

SCHEME

SUDECHAIN

Image may be NSFW.
Clik here to view.

MAIN

Image may be NSFW.
Clik here to view.

Patent

WO2023114995  PFIZER

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023114995&_cid=P20-MB07JE-44537-1

PAPER

Journal of Medicinal Chemistry (2012), 55(21), 9045-9054 

PATENT

WO2008139293

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2008139293&_cid=P20-MB07LY-46583-1

EXAMPLE 111

6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyiτolidin-3-yl]-1-αetrahydro-2H- pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

Image may be NSFW.
Clik here to view.

///////Edelinontrine, CRD740, PF04447943, CRD 740, PF 04447943, PHASE 1


Viewing all articles
Browse latest Browse all 1724

Trending Articles